Use of nebulized antimicrobials for the treatment of respiratory infections in invasively mechanically ventilated adults: a position paper from the European Society of Clinical Microbiology and Infectious Diseases

Clinical Microbiology and Infection

Volumn 23, Issue 9, 2017, Pages 629-639

  Rello, J ^a   Sole Lleonart C ^b   Rouby, J J ^c   Chastre, J ^c   Blot, S ^d   Poulakou, G ^e   Luyt, C E ^c   Riera, J ^f   Palmer, L B ^g   Pereira, J M ^h,i   Felton, T ^j   Dhanani, J ^k   Bassetti, M ^l   Welte, T ^m   Roberts, J A ^k  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d GHENT UNIVERSITY   (Belgium)

^e UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^f INSTITUTO DE SALUD CARLOS III   (Spain)

^g STONY BROOK UNIVERSITY   (United States)

^h Universidade do Porto   (Portugal)

ⁱ University of Porto   (Portugal)

^j MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^k UNIVERSITY OF QUEENSLAND   (Australia)

^l S Maria Hospital   (Italy)

^m HANNOVER MEDICAL SCHOOL   (Germany)

more..

Author keywords

Aminoglycosides; Antibiotic aerosolization; Colistin; Multidrug resistant organisms; Nosocomial pneumonia; Regulatory issues; Ventilator associated pneumonia; Ventilator associated tracheobronchitis

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; COLISTIN; ANTIINFECTIVE AGENT;

ADVERSE OUTCOME; AEROSOL; ANTIBIOTIC THERAPY; ANTIFUNGAL THERAPY; ANTIVIRAL THERAPY; CLINICAL OUTCOME; CRITICALLY ILL PATIENT; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYPOXEMIA; META ANALYSIS; MULTIDRUG RESISTANCE; NEBULIZATION; PHASE 3 CLINICAL TRIAL (TOPIC); PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT INFECTION; SHORT SURVEY; SYSTEMATIC REVIEW; TRACHEOBRONCHITIS; VENTILATED PATIENT; VENTILATOR ASSOCIATED PNEUMONIA; ADMINISTRATION AND DOSAGE; ARTIFICIAL VENTILATION; ENDOTRACHEAL INTUBATION; EUROPE; INFECTIOUS DISEASE MEDICINE; NEBULIZER; ORGANIZATION AND MANAGEMENT; PRACTICE GUIDELINE; THERAPEUTIC USE;

AEROSOLS; ANTI-INFECTIVE AGENTS; EUROPE; HUMANS; INFECTIOUS DISEASE MEDICINE; INTUBATION, INTRATRACHEAL; NEBULIZERS AND VAPORIZERS; PNEUMONIA, VENTILATOR-ASSOCIATED; PRACTICE GUIDELINES AS TOPIC; RESPIRATION, ARTIFICIAL;

EID: 85020263688     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2017.04.011     Document Type: Short Survey

References (47)

1. Mogayzel, P.J., Naureckas, E.T., Robinson, K.A., Mueller, G., Hadjiliadis, D., Hoag, J.B., et al. Cystic fibrosis pulmonary guidelines. Am J Respir Crit Care Med 187 (2013), 680–689.
2. Solé-Lleonart, C., Roberts, J.A., Chastre, J., Poulakou, G., Palmer, L.B., Blot, S., et al. Global survey on nebulization of antimicrobial agents in mechanically ventilated patients: a call for international guidelines. Clin Microbiol Infect 22 (2016), 359–364.
3. Solé-Lleonart, C., Rouby, J.J., Chastre, J., Poulakou, G., Palmer, L.B., Blot, S., et al. Intratracheal administration of antimicrobial agents in mechanically ventilated adults: an International Survey on Delivery Practices and Safety. Respir Care 61 (2016), 1008–1014.
4. Schünemann H, Brozek J, Guyatt G, Oxman A (editors). Handbook for grading the quality of evidence and strength of recommendations using the GRADE approach [updated October 2013]. Available at: www.gradepro.org.
5. Rello, J., Rouby, J.J., Sole-Lleonart, C., Chastre, J., Blot, S., Chastre, J., et al. Nebulisation of antimicrobial agents to mechanically ventilated patients: practical Recommendations for a safe and effective administration—a Consensus Statement. Clin Microbiol Infect, 2017 [in press].
6. Magiorakos, A.P., Srinivasan, A., Carey, R.B., Carmeli, Y., Falagas, M.E., Giske, C.G., et al. Multidrug-resistant, extensively drug-resistant and pandrug resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18 (2012), 268–281.
7. Solé-Lleonart, C., Rouby, J.J., Blot, S., Poulakou, G., Chastre, J., Palmer, L.B., et al. Nebulization of anti-infective agents in invasively mechanically ventilated adults: a systematic review and meta-analysis. Anaesthesiology 126 (2017), 890–908.
8. Niederman, M.S., Chastre, J., Corkery, K., Fink, J.B., Luyt, C.E., Garcia, M.S., BAY41-6551 achieves bactericidal tracheal aspirate amikacin concentrations in mechanically ventilated patients with Gram-negative pneumonia. Intensive Care Med 38 (2012), 263–271.
9. Kofteridis, D.P., Alexopoulou, C., Valachis, A., Maraki, S., Dimopoulou, D., Georgopoulos, D., et al. Aerosolized plus intravenous clistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: a matched case–control study. Clin Infect Dis 51 (2010), 1238–1244.
10. Doshi, N.M., Cook, C.H., Mount, K.L., Stawicki, S.P., Frazee, E.N., Personett, H.A., et al. Adjunctive aerosolized colistin for multi-drug resistant gram-negative pneumonia in the critically ill: a retrospective study. BMC Anesthesiol, 13, 2013, 45.
11. Tumbarello, M., De Pascale, G., Trecarichi, E.M., De Martino, S., Bello, G., Maviglia, R., et al. Effect of aerosolized colistin as adjunctive treatment on the outcomes of microbiologically documented ventilator-associated pneumonia caused by colistin-only susceptible gram-negative bacteria. Chest 144 (2013), 1768–1775.
12. Ghannam, D.E., Rodriguez, G.H., Raad II, Safdar, A., Inhaled aminoglycosides in cancer patients with ventilator-associated Gram-negative bacterial pneumonia: safety and feasibility in the era of escalating drug resistance. Eur J Clin Microbiol Infect Dis 28 (2009), 253–259.
13. Lu, Q., Yang, J., Liu, Z., Gutierrez, C., Aymard, G., Rouby, J.J., Nebulized ceftazidime and amikacin in ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Am J Respir Crit Care Med 184 (2011), 106–115.
14. Palmer, L.B., Smaldone, G.C., Chen, J.J., Baram, D., Duan, T., Monteforte, M., et al. Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit. Crit Care Med 36 (2008), 2008–2013.
15. Palmer, L.B., Smaldone, G.C., Reduction of bacterial resistance with inhaled antibiotics in the Intensive Care Unit. Am J Respir Crit Care Med 189 (2014), 1225–1233.
16. Rattanaumpawan, P., Lorsutthiham, J., Ungprasert, P., Angkasekwinai, N., Thamlikitkul, V., Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria. J Antimicrob Chemother 65 (2010), 2645–2649.
17. Arnold, H.M., Sawyer, A.M., Kollef, M.H., Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia. Respir Care 57 (2012), 1226–1231.
18. Hallal, A., Cohn, S.M., Namias, N., Habib, F., Baracco, G., Manning, R.J., et al. Aerosolized tobramycin in the treatment of ventilator-associated pneumonia: a pilot study. Surg Infect (Larchmt) 8 (2007), 73–82.
19. Abdellatif, S., Trifi, A., Daly, F., Mahjoub, K., Nasri, R., Ben Lakhal, S., Efficacy and toxicity of aerosolized colistin in ventilator-associated pneumonia: a prospective, randomized trial. Ann Intensive Care, 6, 2016, 26.
20. The Cochrane Collaboration Higgins, J.P.T., Green, S., (eds.) Cochrane Handbook for systematic reviews of interventions version 5.1.0 [updated March 2011], 2011 Available at: www.cochrane-handbook.org.
21. Safdar, A., Rodriguez, G.H., Aerosolized amphotericin B lipid complex as adjunctive treatment for fungal lung infection in patients with cancer-related immunosuppression and recipients of hematopoietic stem cell transplantation. Pharmacotherapy 33 (2013), 1035–1043.
22. Ferrari, F., Liu, Z.H., Lu, Q., Becquemin, M.H., Louchahi, K., Aymard, G., et al. Comparison of lung tissue concentrations of nebulized ceftazidime in ventilated piglets: ultrasonic versus vibrating plate nebulizers. Intensive Care Med 34 (2008), 1718–1723.
23. Lu, Q., Girardi, C., Zhang, M., Bouhemad, B., Louchahi, K., Petitjean, O., et al. Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa. Intensive Care Med 36 (2010), 1147–1155.
24. Goldstein, I., Wallet, F., Robert, J., Becquemin, M.H., Marquette, C.H., Rouby, J.J., et al. Lung tissue concentrations of nebulized amikacin during mechanical ventilation in piglets with healthy lungs. Am J Resp Crit Care Med 165 (2002), 171–175.
25. Goldstein, I., Wallet, F., Nicolas-Robin, A., Ferrari, F., Marquette, C.H., Rouby, J.J., et al. Lung deposition and efficiency of nebulized amikacin during E. coli pneumonia in ventilated piglets. Am J Resp Crit Care Med 166 (2002), 1375–1381.
26. Ferrari, F., Goldstein, I., Nieszkowszka, A., Elman, M., Marquette, C.H., Rouby, J.J., Lack of lung tissue and systemic accumulation after consecutive daily aerosols of amikacin in ventilated piglets with healthy lungs. Anesthesiology 98 (2003), 1016–1019.
27. Elman, M., Goldstein, I., Marquette, C.H., Wallet, F., Lenaour, G., Rouby, J.J., et al. Influence of lung aeration on pulmonary concentrations of nebulized and intravenous amikacin in ventilated piglets with severe bronchopneumonia. Anesthesiology 97 (2002), 1999–2006.
28. Tonnellier, M., Ferrari, F., Goldstein, I., Sartorius, A., Marquette, C.H., Rouby, J.J., Intravenous versus nebulized ceftazidime in ventilated piglets with and without experimental bronchopneumonia. Comparative effects of helium and nitrogen. Anesthesiology 102 (2005), 995–1000.
29. Ferrari, F., Girardi, C., Petitjean, O., Marquette, C.H., Wallet, F., Rouby, J.J., et al. Nebulized ceftazidime in experimental pneumonia caused by partially resistant Pseudomonas aeruginosa. Intensive Care Med 35 (2009), 1792–1800.
30. Paul, M., Leibovici, L., Observational studies examining patients management in infectious diseases. Clin Microbiol Infect 23:9 (2017), 127–128.
31. Hahn, M., Tservistas, M., Hetzer, U., In vitro assessment of a novel nebulizer for mechanically ventilated patients based on the eFlow ® technology (abstract). J Aerosol Med Pulm Drug Deliv 22 (2009), 187–188.
32. Rouby, J.J., Bouhemad, B., Monsel, A., Brisson, H., Arbelot, C., Lu, Q., et al. Aerosolized antibiotics for ventilator-associated pneumonia. Anesthesiology 117 (2012), 1364–1380.
33. Lu, Q., Luo, R., Bodin, L., Yang, J., Zahr, N., Aubry, A., et al. Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Anesthesiology 117 (2012), 1335–1347.
34. McCoy, K.S., Compounded colistimethate as possible cause of fatal acute respiratory distress syndrome. N Engl J Med 357 (2007), 2310–2311.
35. Leong, K.W., Ong, S., Chee, H.L., Lee, W., Kwa, L.A., Hypersensitivity pneumonitis due to high-dose colistin aerosol therapy. Int J Infect Dis 14 (2010), 1018–1019.
36. Valcke, Y.J., Vogelaers, D.P., Colardyn, F.A., Pauwels, R., Penetration of netilmicin in the lower respiratory tract after once-daily dosing. Chest 101 (1992), 1028–1032.
37. Panidis, D., Markantonis, S.L., Boutzouka, E., Karatzas, S., Baltopoulo, G., Penetration of gentamicin into the alveolar lining fluid of critically ill patients with ventilator-associated pneumonia. Chest 128 (2005), 545–552.
38. Boselli, E., Breilh, D., Djabarouti, S., Guillaume, C., Rimmele, T., Gordien, J.B., et al. Reliability of mini-bronchoalveolar lavage for the measurement of epithelial lining fluid concentrations of tobramycin in critically ill patients. Intensive Care Med 33 (2007), 1519–1523.
39. Rubinstein, E., Lode, H., Grassi, C., Ceftazidime monotherapy vs. ceftriaxone/tobramycin for serious hospital-acquired gram negative infections. Antibiotic Study Group. Clin Infect Dis 20 (1995), 1217–1228.
40. Sieger, B., Bergman, S., Geckler, R.W., Farkas, S.A., Empiric treatment of hospital-acquired respiratory tract infections with meropenem or ceftazidime with tobramycin: a randomized study. Meropenem Lower Respiratory Infection Group. Crit Care Med 25 (1997), 1663–1670.
41. Paul, M., Benuri-Silbiger, I., Soares-Weiser, K., Leibovici, L., β lactam monotherapy versus β lactam-aminoglyco-side combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomized trials. Brit Med J, 328, 2004, 668.
42. Bliziotis, I.A., Samonis, G., Vardakas, K.Z., Chrysanthopoulou, S., Falagas, M.E., Effect of aminoglycoside and β-lactam combination therapy versus β-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials. Clin Infect Dis 41 (2005), 149–158.
43. Paul, M., Lador, A., Grozinsky-Glasberg, S., Leibovici, L., β lactam antibiotic monotherapy versus β lactam-aminoglycoside antibiotic combination therapy for sepsis. Cochrane Database Syst Rev(1), 2014, CD003344.
44. Sime, F.B., Johnson, A., Whalley, S., Santoyo-Castelazo, A., Montgomery, A.B., Walters, K.A., et al. Pharmacodynamics of aerosolized fosfomycin and amikacin against resistant clinical isolates of Pseudomonas aeruginosa and Klebsiella pneumonia in a hollow infection model: experimental basis for combination therapy. Antimicrob Agents Chemother, 61(1), 2016.
45. Kollef, M.H., Ricard, J.D., Roux, D., François, B., Ischaki, E., Rozgony, Z., et al. A randomized trial of the amikacin fosfomycin inhalation system for the adjunctive therapy of Gram negative ventilator-associated pneumonia (IASIS Trial). Chest, 2016; Nov 24 [Epub Ahead of print].
46. Boe, J., Dennis, J.H., O'Driscoll, B.R., Bauer, T.T., Carone, M., Dautzerberg, B., et al. European Respiratory Society guidelines on the use of nebulizers. Eur Resp J 18 (2001), 228–242.
47. Le, J., Ashley, E.D., Neuhauser, M.M., Brown, J., Gentry, C., Klepser, M.E., et al. Consensus summary of aerosolized antimicrobial agents: application of guideline criteria, insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy 30 (2010), 562–584.